Point72 Hong Kong LTD Beyond Spring Inc. Transaction History

Point72 Hong Kong LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.68 - $5.01 $3,183 - $9,493	-1,895 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.02 - $16.84 $7,617 - $31,911	1,895 New	1,895 $9,000
Q1 2021 May 17, 2021	SELL	$10.61 - $15.77 $4,445 - $6,607	-419 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$10.21 - $17.31 $4,277 - $7,252	419 New	419 $5,000

5.63M

288K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $76.3M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.